Literature DB >> 28472373

Association Between Bacillus Calmette-Guérin Vaccination and Childhood Asthma in the Quebec Birth Cohort on Immunity and Health.

Mariam El-Zein, Florence Conus, Andrea Benedetti, Dick Menzies, Marie-Elise Parent, Marie-Claude Rousseau.   

Abstract

We estimated the association between bacillus Calmette-Guérin (BCG) vaccination and childhood asthma in a birth cohort using administrative databases, and we determined the impact of adjusting for potential confounders collected from a subset of the cohort members. Data were collected in 2 waves: 1) Administrative data for 76,623 individuals (stage 1) was gathered from the Quebec Birth Cohort on Immunity and Health (1974-1994), including BCG vaccination status, perinatal and sociodemographic characteristics, and use of health services for asthma; and 2) self-reported asthma risk factors were collected in 2012 by telephone interviews with 1,643 participants (stage 2) using a balanced 2-stage sampling design. We estimated odds ratios and 95% confidence intervals for asthma using logistic regression and correcting for the known sampling fractions from stage 1 to stage 2, overall and sex-stratified. In total, 35,612 (46.5%) individuals were BCG vaccinated, and 5,870 (7.7%) had asthma. The final odds ratio, integrating results from both stages of sampling, was 0.95 (95% confidence interval: 0.87, 1.04). Results did not differ according to sex (P for interaction = 0.327). To our knowledge, this is the largest study ever conducted on this topic, and using the best possible comprehensive adjustment for confounders, we found no association between BCG vaccination and asthma.
© The Author(s) 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  2-stage sampling; administrative data; asthma; bacillus Calmette-Guérin; birth cohort

Mesh:

Substances:

Year:  2017        PMID: 28472373      PMCID: PMC5860497          DOI: 10.1093/aje/kwx088

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  45 in total

1.  Two-stage case-control studies: precision of parameter estimates and considerations in selecting sample size.

Authors:  James A Hanley; Ilona Csizmadi; Jean-Paul Collet
Journal:  Am J Epidemiol       Date:  2005-11-03       Impact factor: 4.897

2.  Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?

Authors:  S J Rolnick; E D Parker; J D Nordin; B D Hedblom; F Wei; T Kerby; J M Jackson; A L Crain; G Euler
Journal:  Vaccine       Date:  2013-06-24       Impact factor: 3.641

3.  The partial questionnaire design for case-control studies.

Authors:  S Wacholder; R J Carroll; D Pee; M H Gail
Journal:  Stat Med       Date:  1994 Mar 15-Apr 15       Impact factor: 2.373

4.  Evaluating the Validity of a Two-stage Sample in a Birth Cohort Established from Administrative Databases.

Authors:  Mariam El-Zein; Florence Conus; Andrea Benedetti; Marie-Elise Parent; Marie-Claude Rousseau
Journal:  Epidemiology       Date:  2016-01       Impact factor: 4.822

5.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates.

Authors:  F D Martinez; A L Wright; L M Taussig; C J Holberg; M Halonen; W J Morgan
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

6.  [The long controversy over anti-tuberculosis vaccination in Canada: the Calmette-Guerin bacillus (BCG), 1925-1975].

Authors:  P Malissard
Journal:  Can Bull Med Hist       Date:  1998

Review 7.  Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination.

Authors:  Marie-Claude Rousseau; Marie-Elise Parent; Yves St-Pierre
Journal:  Pediatr Allergy Immunol       Date:  2007-12-27       Impact factor: 6.377

8.  Determinants of Bacillus Calmette-Guérin (BCG) vaccination among Québec children.

Authors:  J Li; D Menzies; J S Landry; A Benedetti; M C Rousseau
Journal:  Prev Med       Date:  2014-06-16       Impact factor: 4.018

9.  Neonatal vaccination with Bacillus Calmette-Guérin elicits long-term protection in mouse-allergic responses.

Authors:  H Shen; H Huang; J Wang; S Ye; W Li; K Wang; G Zhang; P Wang
Journal:  Allergy       Date:  2008-02-23       Impact factor: 13.146

10.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16
View more
  6 in total

1.  Cohort Profile: The Québec Birth Cohort on Immunity and Health (QBCIH).

Authors:  Marie-Claude Rousseau; Mariam El-Zein; Florence Conus; Marie-Elise Parent; Andrea Benedetti
Journal:  Int J Epidemiol       Date:  2018-08-01       Impact factor: 7.196

Review 2.  Mycobacterium-Induced Th1, Helminths-Induced Th2 Cells and the Potential Vaccine Candidates for Allergic Asthma: Imitation of Natural Infection.

Authors:  Mohamed Hamed Abdelaziz; Xiaoyun Ji; Jie Wan; Fatma A Abouelnazar; Sayed F Abdelwahab; Huaxi Xu
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

3.  Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.

Authors:  Matthew F Daley; Jo Ann Shoup; Sophia R Newcomer; Michael L Jackson; Holly C Groom; Steven J Jacobsen; Huong Q McLean; Nicola P Klein; Eric S Weintraub; Michael M McNeil; Jason M Glanz
Journal:  Acad Pediatr       Date:  2018-03-28       Impact factor: 3.107

4.  BCG Vaccination in Early Childhood and Risk of Atopic Disease: A Systematic Review and Meta-Analysis.

Authors:  Keyu Zhao; Phoebe Miles; Xinyu Jiang; Qiongyan Zhou; Chao Cao; Wei Lin; Richard Hubbard; Panfeng Fu; Suling Xu
Journal:  Can Respir J       Date:  2021-11-24       Impact factor: 2.409

Review 5.  The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.

Authors:  Kiddus Yitbarek; Gelila Abraham; Tsinuel Girma; Tizta Tilahun; Mirkuzie Woldie
Journal:  Vaccine       Date:  2020-08-10       Impact factor: 3.641

6.  S3 guideline Allergy Prevention.

Authors:  Matthias V Kopp; Cathleen Muche-Borowski; Michael Abou-Dakn; Birgit Ahrens; Kirsten Beyer; Katharina Blümchen; Petra Bubel; Adam Chaker; Monika Cremer; Regina Ensenauer; Michael Gerstlauer; Uwe Gieler; Inga-Marie Hübner; Fritz Horak; Ludger Klimek; Berthold V Koletzko; Sybille Koletzko; Susanne Lau; Thomas Lob-Corzilius; Katja Nemat; Eva M J Peters; Antonio Pizzulli; Imke Reese; Claudia Rolinck-Werninghaus; Elien Rouw; Bianca Schaub; Sebastian Schmidt; Jens-Oliver Steiß; Anne Kathrin Striegel; Zsolt Szépfalusi; Dietmar Schlembach; Thomas Spindler; Christian Taube; Valérie Trendelenburg; Regina Treudler; Ulrich Umpfenbach; Christian Vogelberg; Martin Wagenmann; Anke Weißenborn; Thomas Werfel; Margitta Worm; Helmut Sitter; Eckard Hamelmann
Journal:  Allergol Select       Date:  2022-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.